Research library Handling & Storage
Laboratory handling
How Should Lyophilized Peptides Be Stored?
Article
Handling & Storage · 6 MIN READ · HANDLING
01 / Overview
Protecting the solid state
Lyophilization exists because peptides in solution degrade and peptides as dry solids largely do not. The freeze-dried cake in a sealed vial is the stable form of the material; almost everything that shortens a peptide's usable life happens after that seal is broken or that cake is dissolved. Storage practice is therefore mostly about protecting the solid state, and the rules are few.
Moisture first
A lyophilized solid is hygroscopic: exposed to ambient air it takes up water, and bound water enables the hydrolytic reactions that dry storage prevents. Water in the cake acts as a plasticizer, restoring the molecular mobility that freeze-drying removed, which is why residual moisture is a controlling variable of solid-state stability [1][2]. The practical consequences: keep the vial sealed until use, and when a vial comes out of a freezer, let it reach room temperature before opening it - opening a cold vial condenses room moisture directly onto the cake. This one habit costs thirty minutes and prevents the commonest avoidable degradation.
A desiccant in the storage container - the silica packet that ships with many materials - earns its place the same way: it keeps the air around the vial dry, so that each opening of the outer container costs nothing. The desiccant belongs with the vials; it does nothing inside a freezer bag it was never put in.
Temperature second
Chemical degradation rates fall with temperature; freezer storage at minus 20 degrees Celsius is the standard condition for lyophilized peptides, and colder does no harm. Brief ambient excursions - shipping, a bench session - are tolerated by the dry solid, which is why lyophilized peptides ship without cold chain. Ambient transit is a designed-for condition; ambient storage as a habit is not.
The tiering is chemistry, not convention. Solid-state degradation - deamidation, oxidation, aggregation - continues at all temperatures, just slowly; published solid-state studies document measurable change in stored peptide solids on long timescales even under good conditions [1][3]. Minus 20 buys years for most sequences; a refrigerator buys months to a year; a drawer at room temperature spends the material's margin for no reason. The freezer also removes temperature cycling, which matters because every warm-cold cycle is another opportunity for condensation at the next opening.
Light third
Tryptophan, tyrosine and methionine-containing sequences are photosensitive to varying degrees. Amber glass or a closed box solves this completely; "protect from light" on a label is asking for exactly that and no more.
Oxidation last
Methionine and cysteine residues oxidize on air exposure over time. For sealed vials this is a slow process; for material repeatedly opened and re-closed it accelerates. Sequences without these residues - BPC-157 among them, which contains neither methionine nor cysteine - are correspondingly less oxidation-prone as solids [3].
After reconstitution, the clock runs faster
A dissolved peptide is exposed to hydrolysis continuously. Solutions are refrigerated, kept from light, and used within a limited window; the window is sequence-dependent and no single figure covers all materials. Two habits extend it honestly: preparing only the volume needed, and dividing a prepared solution into aliquots so that no portion is repeatedly frozen and thawed - freeze-thaw cycling degrades peptide solutions faster than either state alone [3].
What storage cannot fix
Storage preserves what arrived; it does not improve it. A lot with poor net peptide content or failed identity testing is not rescued by a good freezer. Storage conditions describe how to keep the material in the state its certificate describes - the certificate, not the freezer, is what says what that state was.
What does a sensible storage setup look like?
Nothing elaborate: sealed vials in a closed, labeled container with a desiccant packet, in a minus 20 freezer that is not defrosted on a cycle, away from the door shelf where temperature swings are largest. Vials leave the freezer only when needed, warm before opening, and go back sealed. The entire discipline fits in two sentences, and the expensive part - the years of shelf life it preserves - was already paid for in the lyophilization.
Frequently asked questions
Can lyophilized peptides be shipped at room temperature?
Yes. Brief ambient excursions such as shipping are tolerated by the dry solid. Ambient storage as a habit is not.
Why should a cold vial warm up before it is opened?
Opening a cold vial condenses room moisture directly onto the cake, and bound water enables the hydrolytic reactions that dry storage prevents.
How should a reconstituted solution be kept?
Refrigerated, protected from light, prepared only in the volume needed and divided into aliquots so that no portion is repeatedly frozen and thawed.
Is a frost-free freezer a problem?
Frost-free cycles work by periodically warming, which adds temperature cycling. Sealed dry vials tolerate it, but a non-cycling freezer or an interior compartment away from the cycling element is the better home for long holds.
Does freezer storage change the peptide?
No. The dry solid has no liquid water to freeze, so freezer temperature cycling does not produce the freeze-thaw damage that affects solutions; it simply slows chemistry.
Key facts
- Temperature Minus 20 degrees Celsius is the standard condition for sealed lyophilized vials
- Moisture The solid is hygroscopic; let a cold vial reach room temperature before opening
- Light Amber glass or a closed box
- Oxidation-prone residues Methionine and cysteine; sequences without them, such as BPC-157, are less affected
Footnotes & references
References
- Lai MC, Topp EM. Solid-state chemical stability of proteins and peptides. J Pharm Sci. 1999;88(5):489-500. PMID: 10229638.
- Chemical stability of peptides in polymers: discriminating between solvent and plasticizing effects of water. J Pharm Sci. 1999;88(10). PMID: 10514359.
- Manning MC, Chou DK, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. PMID: 20143256.
Related products & records
Read the specification and the record
Use the lot record and testing pages for the source analytical documentation.
Related reading